john carter
author
- Total Post (41)
Articles By This Author

India may find it difficult to win back 100% broken rice importers
- By john carter
- . March 12, 2025
India will likely find it difficult to woo back global buyers of broken rice after the government lifted the ban on its exports on March

Aroma Agrotech to diversify into food manufacturing, textiles, renewable energy
- By john carter
- . March 12, 2025
Haryana-based Aroma Agrotech, which sells basmati rice under the AAT Aroma brand, plans to diversify into food manufacturing, including wheat flour, textiles and renewable energy,
Arun Mammen elected as new ATMA chairman
- By john carter
- . March 12, 2025
Arun Mammen, Vice Chairman & Managing Director of MRF Ltd, has been elected as the new Chairman of Automotive Tyre Manufacturers’ Association (ATMA), the national

Zydus gains FDA approval for urinary tract infection medication
- By john carter
- . March 12, 2025
Zydus Lifesciences Limited announced today it has received final approval from the US Food and Drug Administration (USFDA) to manufacture Methenamine Hippurate Tablets USP, 1

KKR-backed Hector Asia and KIA EBT Seek CCI Nod for majority stake buy in Healthcare Global Enterprises
- By john carter
- . March 12, 2025
Global investment firm KKR & Co., through its subsidiary Hector Asia Holdings II Pte. Ltd., in collaboration with KIA EBT II Scheme 1, has moved

ICRA pegs the growth of IT services firms at 4-6% in 2025-26
- By john carter
- . March 12, 2025
Indian IT services companies are likely to witness a moderate growth of 4-6 per cent in revenues in 2025-26, according to rating firm ICRA. It

White House press secretary criticises India’s tariff on alcohol, agriculture products
- By john carter
- . March 12, 2025
Keeping up pressure on India to slash its import tariffs on US goods, White House press secretary Karoline Leavitt has said that India imposed 150

Day 1 after diabetes drug Empagliflozin goes off patent, generics go to town with it
- By john carter
- . March 12, 2025
Drugmakers have begun to roll-out their generic versions of diabetes drug Empagliflozin – on day one after the innovative drug from Boehringer Ingelheim (BI) went

Top gainers & losers intraday March 12, 2025: IndusInd lead gains, IT stocks Infosys, Wipro, Tech Mahindra drag
- By john carter
- . March 12, 2025
Shares of IndusInd Bank, Kotak Mahindra Bank, Tata Motors, HDFC Bank and Sun Pharma traded among top gainers of Nifty 50. IT stocks faced significant

Glenmark expands diabetes portfolio with new Empagliflozin treatments
- By john carter
- . March 12, 2025
Glenmark Pharmaceuticals announced today the launch of Empagliflozin and its fixed-drug combinations in India under the brand names Glempa, Glempa-L, and Glempa-M. The shares of